(3aR,4R,6R,6aR)-4-methoxy-2,2,6-trimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole

We are (3aR,4R,6R,6aR)-4-methoxy-2,2,6-trimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole CAS:23202-81-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(3aR,4R,6R,6aR)-4-methoxy-2,2,6-trimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole
CAS.NO:23202-81-5
Synonyms:(3aR,4R,6R,6aR)-4-methoxy-2,2,6-trimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole
methyl 5-deoxy-2,3-o-isopropylidene-|A-d-ribofuranoside
Methyl 5-deoxy-2,3-O-isopropylidene-beta-D-ribofuranoside
 
Physical and Chemical Properties:
Density 1.11 g/cm3
Boiling Point 225.6ºC at 760 mmHg
Molecular Formula C9H16O4
Molecular Weight 188.22100
Flash Point 88.6ºC
Vapour Pressure 0.128mmHg at 25°C
Index of Refraction 1.465
 
Specification:
Appearance:White crystalline powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Capecitabine(CAS:154361-50-9).

(3aR,4R,6R,6aR)-4-methoxy-2,2,6-trimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole


Related News: Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.66762-68-3 It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.(R)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API.3-Bromo-2-fluorobenzotrifluoride Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.

Related Products
Product Name
1-hexyl-2,3-dimethylimidazolium bromide View Details
3,4,5-Trifluorophenylboronic acid View Details
2-Amino-3-Bromo-6-Methylpyridine View Details
5-Chloropyridine-2-carboxylic Acid manufacturer 2-(Difluoromethoxy)aniline manufacturer (3R)-3-<(tert-Butyldimethylsilyl)oxy>pentanedioic acid 1-<(R)-mandelic acid> ester manufacturer 5-Fluoro-2-nitrobenzoic acid manufacturer UV Absorber 928 manufacturer